主题：NeuroEngineering and Rehabilitation
时间：2025年6月26日15：00-16：00
地点：2教228
主持人：佘青山教授
报告人简介：
主持人简介：
Yingchun Zhang 教授
Yingchun Zhang is a Professor in the Department of Biomedical Engineering, Miami Project to Cure Paralysis, Desai Sethi Urology Institute, and the director of the Engineering for Precision Rehabilitation (EPR) Laboratory at the University of Miami, Coral Gables, FL USA. Dr. Zhang is a recipient of NIH Pathway to Independence (K99/R00) award, a recipient of the 12th Annual Delsys Prize for Innovation in Electromyography, a recipient of University of Houston Engineering Rising Innovator award, and a fellow of the American Institute of Medical Biological Engineering (AIMBE). His high-density surface EMG work was selected as the SUFU Clinical Science Essay Award. As an inventor of 8 patents, Dr. Zhang is also the Founder and Chief Executive Officer (CEO) of HillMed Inc, a medical device startup established to commercialize his advanced high-density surface EMG technology for neuromuscular disease assessment and precision treatment. HillMed recently received a Phase II and two Phase I SBIR awards to support the effort of obtaining the FDA clearance (510k) of its devices. He serves as a standing member for the NIH study section: Motor Function, Speech and Rehabilitation (MFSR), and an associate editor for several peer-reviewed journals, including IEEE Transactions on Neural Systems and Rehabilitation Engineering, Journal of NeuroEngineering and Rehabilitation, and Neurourology and Urodynamics. Zhang's research aims to achieve the long-term goal of advancing Precision Rehabilitation. This will be accomplished through the comprehensive assessment of brain and muscle activation dynamics, as well as brain-muscle interaction, using a combination of multimodal neuroimaging, neuroengineering, neuromodulation and machine learning techniques. Dr. Zhang has authored over 180 peer-reviewed scientific journal articles.
报告题目：Precision Phenotyping and Personalized Neuromodulation for Advanced Neural Rehabilitation
摘要：This talk will highlight recent advancements in precision diagnosis, phenotyping, and mechanism-driven interventions for neurological and neuromuscular disorders, including movement disorders, pain, and psychiatric conditions, through multimodal assessment of brain and muscle dynamics, as well as brain-muscle interactions. I will discuss the integration of neuroimaging, neuroengineering, and neuromodulation techniques including EEG, MRI, fNIRS, high-density surface EMG, TMS, and tACS, into a unified framework. This multimodal approach enables quantitative evaluation of changes in three key domains: (1) brain function, (2) neuromuscular function, and (3) brain-muscle interaction, and provides insights into their roles in the pathophysiology of neuromuscular diseases. I will introduce our functional brain controllability analysis approach, which supports the diagnosis and phenotyping of depression and movement disorders, and enables personalized neuromodulation interventions. I will also present our novel muscle network analysis framework, developed for phenotyping and personalizing neural rehabilitation in stroke and chronic pelvic pain.